Index -
P/E 15.51
EPS (ttm) 4.11
Insider Own 0.24%
Shs Outstand 498.94M
Perf Week 1.92%
Market Cap 31.78B
Forward P/E 21.70
EPS next Y 2.93
Insider Trans 0.00%
Shs Float 497.72M
Perf Month 13.71%
Income 1.94B
PEG -
EPS next Q 0.60
Inst Own 67.74%
Short Float 1.40%
Perf Quarter 30.11%
Sales 6.63B
P/S 4.80
EPS this Y 28.16%
Inst Trans 2.15%
Short Ratio 2.02
Perf Half Y 28.95%
Book/sh 39.06
P/B 1.63
EPS next Y 2.67%
ROA 7.44%
Short Interest 6.94M
Perf Year 13.43%
Cash/sh 0.70
P/C 91.09
EPS next 5Y -0.70%
ROE 10.89%
52W Range 43.22 - 64.19
Perf YTD 16.12%
Dividend Est. 1.38 (2.17%)
P/FCF 34.24
EPS past 5Y -
ROI 9.12%
52W High -0.79%
Beta 1.05
Dividend TTM 1.60 (2.51%)
Quick Ratio 0.74
Sales past 5Y 25.35%
Gross Margin 29.97%
52W Low 47.36%
ATR (14) 1.60
Dividend Ex-Date Feb 29, 2024
Current Ratio 2.09
EPS Y/Y TTM 172.31%
Oper. Margin 26.07%
RSI (14) 67.14
Volatility 1.96% 2.50%
Employees 15875
Debt/Eq 0.10
Sales Y/Y TTM 15.43%
Profit Margin 29.29%
Recom 1.35
Target Price 75.55
Option/Short Yes / Yes
LT Debt/Eq 0.10
EPS Q/Q -270.53%
Payout 40.51%
Rel Volume 0.81
Prev Close 62.92
Sales Surprise 2.00%
EPS Surprise 14.90%
Sales Q/Q 26.86%
Earnings Apr 25 AMC
Avg Volume 3.43M
Price 63.69
SMA20 3.91%
SMA50 14.76%
SMA200 24.65%
Trades
Volume 2,785,158
Change 1.22%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-29-24 Initiated
Jefferies
Hold
$54
Apr-03-23 Resumed
BMO Capital Markets
Outperform
$57 → $60
Sep-30-22 Upgrade
Citigroup
Neutral → Buy
Sep-12-22 Initiated
Goldman
Buy
Feb-10-22 Resumed
BMO Capital Markets
Outperform
Feb-03-22 Upgrade
Barclays
Equal Weight → Overweight
$67 → $69
Jan-28-22 Upgrade
National Bank Financial
Sector Perform → Outperform
Oct-06-21 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$68 → $63
Sep-24-21 Initiated
KeyBanc Capital Markets
Sector Weight
Sep-10-21 Downgrade
National Bank Financial
Outperform → Sector Perform
Feb-10-21 Initiated
JP Morgan
Neutral
Oct-19-20 Downgrade
Barclays
Overweight → Equal Weight
Jul-30-20 Upgrade
Scotiabank
Sector Perform → Sector Outperform
Mar-02-20 Upgrade
Canaccord Genuity
Hold → Buy
Feb-18-20 Downgrade
Scotiabank
Sector Outperform → Sector Perform
Dec-11-19 Upgrade
Barclays
Equal Weight → Overweight
Dec-05-19 Resumed
RBC Capital Mkts
Sector Perform
Apr-12-19 Downgrade
Desjardins
Buy → Hold
Sep-10-18 Resumed
Credit Suisse
Outperform
Aug-09-18 Upgrade
National Bank Financial
Sector Perform → Outperform
Show Previous Ratings
Today 08:38AM
Apr-19-24 06:00PM
Apr-18-24 06:15PM
10:01AM
Apr-13-24 01:52PM
06:15PM
Loading…
Apr-12-24 06:15PM
Apr-10-24 01:48PM
(Investor's Business Daily)
Apr-09-24 12:47PM
10:00AM
Apr-08-24 03:47PM
Apr-04-24 03:47PM
12:10PM
07:00AM
Apr-02-24 03:00PM
(Investor's Business Daily)
02:47PM
10:29AM
Loading…
Apr-01-24 10:29AM
Mar-25-24 07:30AM
Mar-24-24 08:10AM
Mar-21-24 10:00AM
Mar-18-24 07:22AM
Mar-15-24 05:27PM
Mar-06-24 01:30PM
Mar-04-24 08:15PM
10:00AM
Feb-29-24 04:14PM
10:35AM
10:00AM
08:00AM
Feb-28-24 05:00PM
Feb-22-24 10:03AM
07:00AM
Loading…
07:00AM
Feb-19-24 10:28AM
Feb-18-24 11:20PM
08:47AM
Feb-15-24 06:15PM
05:30PM
05:25PM
(Associated Press Finance)
05:00PM
Feb-14-24 08:38AM
Feb-12-24 06:56AM
Feb-10-24 12:10AM
Feb-08-24 10:00AM
Feb-06-24 02:10PM
Jan-25-24 04:07PM
Jan-16-24 12:10PM
Jan-15-24 11:16PM
Jan-13-24 04:52PM
Jan-11-24 05:00AM
Jan-10-24 09:30AM
08:45AM
Jan-08-24 07:30AM
Jan-02-24 12:11PM
Dec-29-23 05:00PM
Dec-26-23 08:33AM
Dec-23-23 07:37PM
03:07PM
Dec-22-23 06:20AM
Dec-20-23 05:17PM
05:00AM
Dec-18-23 08:34AM
04:55AM
Dec-15-23 09:40AM
09:13AM
Dec-11-23 05:48PM
Dec-08-23 11:24AM
Dec-07-23 09:00AM
Dec-06-23 07:00AM
Dec-05-23 09:48AM
Nov-30-23 09:12AM
07:45AM
Nov-29-23 03:19AM
Nov-24-23 11:31AM
Nov-22-23 02:42PM
10:45AM
Nov-16-23 09:00AM
Nov-15-23 04:10PM
Nov-14-23 06:30AM
Nov-13-23 09:57PM
05:59PM
04:41PM
Nov-09-23 02:15PM
Nov-08-23 07:00AM
Nov-06-23 05:30PM
Nov-02-23 08:30AM
Oct-31-23 02:58AM
Oct-27-23 02:23PM
07:00AM
Oct-26-23 11:52PM
11:40AM
06:35AM
Oct-25-23 06:40PM
05:32PM
(Associated Press Finance)
05:00PM
Oct-18-23 10:01AM
Oct-17-23 08:12PM
Oct-16-23 12:58AM
Oct-10-23 08:30AM
Oct-04-23 01:47PM
Oct-03-23 07:30AM
Oct-02-23 11:40AM
Agnico Eagle Mines Ltd. engages in the exploration and production of gold. It operates through the following segments: Northern Business, Southern Business, and Exploration. The Northern Business segment comprises of LaRonde mine, LaRonde Zone 5 mine, Lapa mine, Goldex mine, Meadowbank mine including the Amaruq deposit, Canadian Malartic joint operation, Meliadine project and Kittila mine. The Southern Business segment consists of Pinos Altos mine, Creston Mascota mine, and La India mine. The Exploration segment represents the exploration offices in the United States, Europe, Canada, and Latin America. The company was founded by Paul Penna in 1957 and is headquartered in Toronto, Canada.
Index -
P/E 33.64
EPS (ttm) 0.26
Insider Own -
Shs Outstand 12.45M
Perf Week 0.24%
Market Cap 110.54M
Forward P/E -
EPS next Y -
Insider Trans -
Shs Float 12.45M
Perf Month -1.32%
Income 3.30M
PEG -
EPS next Q -
Inst Own 28.40%
Short Float 0.08%
Perf Quarter -2.08%
Sales 4.40M
P/S 25.12
EPS this Y 107.40%
Inst Trans 15.86%
Short Ratio 0.30
Perf Half Y 4.11%
Book/sh 9.57
P/B 0.93
EPS next Y -
ROA -
Short Interest 0.01M
Perf Year -4.30%
Cash/sh 0.11
P/C 78.96
EPS next 5Y -
ROE -
52W Range 8.28 - 9.45
Perf YTD 0.69%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI 2.80%
52W High -6.02%
Beta 0.24
Dividend TTM 0.31 (3.51%)
Quick Ratio -
Sales past 5Y -
Gross Margin 85.80%
52W Low 7.26%
ATR (14) 0.11
Dividend Ex-Date Apr 12, 2024
Current Ratio -
EPS Y/Y TTM -
Oper. Margin 85.50%
RSI (14) 46.60
Volatility 0.93% 1.29%
Employees -
Debt/Eq 0.00
Sales Y/Y TTM -
Profit Margin 74.00%
Recom -
Target Price -
Option/Short No / Yes
LT Debt/Eq 0.00
EPS Q/Q -249.20%
Payout 112.50%
Rel Volume 0.59
Prev Close 8.89
Sales Surprise -
EPS Surprise -
Sales Q/Q 9.50%
Earnings -
Avg Volume 31.84K
Price 8.88
SMA20 -0.33%
SMA50 -0.60%
SMA200 0.51%
Trades
Volume 18,832
Change -0.11%
Index -
P/E 5.35
EPS (ttm) 1.43
Insider Own 0.20%
Shs Outstand 12.99M
Perf Week 1.46%
Market Cap 99.38M
Forward P/E -
EPS next Y -
Insider Trans 0.00%
Shs Float 12.96M
Perf Month -2.17%
Income -
PEG -
EPS next Q -
Inst Own 40.75%
Short Float 0.12%
Perf Quarter -3.89%
Sales 2.94M
P/S 33.76
EPS this Y -
Inst Trans -
Short Ratio 1.05
Perf Half Y 5.50%
Book/sh 9.76
P/B 0.78
EPS next Y -
ROA -
Short Interest 0.02M
Perf Year -8.38%
Cash/sh -
P/C -
EPS next 5Y -
ROE -
52W Range 7.12 - 8.57
Perf YTD -6.71%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -
52W High -10.69%
Beta 0.81
Dividend TTM 0.50 (6.58% )
Quick Ratio -
Sales past 5Y -
Gross Margin -
52W Low 7.44%
ATR (14) 0.08
Dividend Ex-Date Mar 18, 2024
Current Ratio -
EPS Y/Y TTM -
Oper. Margin -
RSI (14) 45.05
Volatility 0.64% 0.77%
Employees -
Debt/Eq -
Sales Y/Y TTM -
Profit Margin -
Recom -
Target Price -
Option/Short No / Yes
LT Debt/Eq -
EPS Q/Q -25.80%
Payout -
Rel Volume 0.93
Prev Close 7.70
Sales Surprise -
EPS Surprise -
Sales Q/Q -16.10%
Earnings -
Avg Volume 15.09K
Price 7.65
SMA20 -0.75%
SMA50 -2.28%
SMA200 -2.99%
Trades
Volume 14,031
Change -0.65%
Mar-08-24 09:05AM
Dec-08-23 03:25PM
Sep-19-23 12:22PM
Sep-15-23 11:13AM
Sep-07-23 12:23PM
09:53AM
Loading…
Jun-09-23 09:53AM
Mar-09-23 02:40PM
Dec-16-22 04:00PM
Dec-09-22 11:10AM
Sep-16-22 05:15PM
Sep-08-22 01:19PM
Jun-07-22 09:50AM
Apr-01-22 04:00PM
Mar-04-22 09:33AM
Dec-13-21 11:35AM
04:31PM
Loading…
Dec-10-21 04:31PM
Sep-14-21 06:48PM
Sep-09-21 11:50AM
Aug-19-21 02:11PM
Jun-10-21 11:22AM
Mar-12-21 04:15PM
Nov-25-20 04:01PM
Sep-16-20 03:48PM
Sep-11-20 03:16PM
Aug-31-20 05:34PM
Jun-10-20 05:11PM
Mar-10-20 06:12PM
Jan-14-20 12:16PM
Dec-13-19 08:25AM
Dec-06-19 11:50AM
04:57PM
Loading…
Nov-07-19 04:57PM
Nov-01-19 09:52AM
Oct-04-19 04:45PM
Jul-29-19 06:12PM
Jan-25-19 04:40PM
Dec-07-18 05:40PM
Nov-20-18 01:00PM
Nov-19-18 06:00AM
Oct-22-18 06:07PM
Oct-17-18 06:38PM
Sep-07-18 04:55PM
Aug-23-18 04:30PM
Jul-20-18 04:10PM
Jul-03-18 01:32PM
Jun-29-18 04:15PM
Jun-25-18 04:15PM
Jun-12-18 04:15PM
Jun-08-18 05:44PM
May-29-18 05:44PM
Dec-07-17 04:47PM
Dec-04-17 04:35PM
Aug-18-17 04:05PM
Jul-07-17 05:11PM
Jun-27-17 04:05PM
Jun-19-17 08:00AM
Apr-26-17 08:30AM
Apr-25-17 08:30AM
Apr-17-17 04:05PM
Mar-28-17 04:01PM
Mar-22-17 04:10PM
Dec-23-16 11:23AM
Dec-06-16 05:05PM
Dec-05-16 05:21PM
Dec-02-16 01:04PM
Nov-11-16 04:40PM
Nov-07-16 05:24PM
12:04AM
(The Wall Street Journal)
Nov-02-16 12:41PM
Jun-23-16 06:29PM
Jun-20-16 05:02PM
Mar-03-16 02:01PM
Dec-08-15 05:35PM
Oct-27-15 06:02AM
Jun-25-15 05:01PM
06:02AM
Mar-17-15 05:12PM
Jan-23-15 06:01AM
Jan-22-15 06:26PM
Dec-03-14 06:29PM
Jul-23-14 03:25PM
Jul-08-14 07:00AM
Jul-07-14 04:31PM
Jul-01-14 11:23AM
Jun-27-14 12:58PM
06:02AM
Jun-04-14 01:17PM
Apr-18-14 03:14PM
Mar-31-14 10:22AM
Feb-18-14 11:50AM
Feb-13-14 04:34PM
Feb-12-14 09:19AM
Jan-21-14 11:50AM
Jan-13-14 09:11AM
Dec-03-13 04:57PM
Oct-28-13 12:59PM
Sep-26-13 05:21PM
Jun-20-13 04:54PM
Jun-19-13 06:04PM
Jun-18-13 10:16AM
Mar-14-13 09:15AM
The Swiss Helvetia Fund Inc. is a closed-ended equity mutual fund launched and managed by Schroder Investment Management North America Inc. The fund invests in public equity markets of Switzerland. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in value stocks of companies across all market capitalizations. It employs fundamental analysis with a bottom-up stock picking approach, focusing on factors such as capital appreciation, income, economic and industry trends, quality of management, financial condition, business plan, industry and sector market position, dividend payout ratio, and corporate governance to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P 500 Index and MSCI EAFE Index. It was previously known as The Helvetia Fund, Inc. The Swiss Helvetia Fund Inc. was formed in October 24, 1986 and is domiciled in the United States.
Index -
P/E 13.66
EPS (ttm) 2.99
Insider Own 0.01%
Shs Outstand 2.03B
Perf Week 3.18%
Market Cap 82.91B
Forward P/E 9.32
EPS next Y 4.38
Insider Trans 0.00%
Shs Float 2.03B
Perf Month -4.60%
Income 6.13B
PEG 2.85
EPS next Q 0.92
Inst Own 14.98%
Short Float 0.24%
Perf Quarter 4.69%
Sales 37.73B
P/S 2.20
EPS this Y -1.96%
Inst Trans 0.60%
Short Ratio 1.36
Perf Half Y 14.13%
Book/sh 8.39
P/B 4.87
EPS next Y 13.20%
ROA 8.31%
Short Interest 4.83M
Perf Year 11.49%
Cash/sh 3.26
P/C 12.55
EPS next 5Y 4.80%
ROE 41.19%
52W Range 33.33 - 43.84
Perf YTD 10.25%
Dividend Est. 1.52 (3.73%)
P/FCF 13.31
EPS past 5Y 4.23%
ROI 16.84%
52W High -6.80%
Beta 0.67
Dividend TTM 1.47 (3.59%)
Quick Ratio 0.62
Sales past 5Y -1.06%
Gross Margin 70.52%
52W Low 22.59%
ATR (14) 0.59
Dividend Ex-Date Feb 22, 2024
Current Ratio 0.88
EPS Y/Y TTM -64.86%
Oper. Margin 22.97%
RSI (14) 47.97
Volatility 1.40% 1.25%
Employees 70212
Debt/Eq 1.35
Sales Y/Y TTM -4.87%
Profit Margin 16.25%
Recom 2.36
Target Price 46.73
Option/Short Yes / Yes
LT Debt/Eq 1.14
EPS Q/Q -75.40%
Payout 47.48%
Rel Volume 0.47
Prev Close 41.24
Sales Surprise 6.12%
EPS Surprise 0.08%
Sales Q/Q 15.46%
Earnings May 01 BMO
Avg Volume 3.56M
Price 40.86
SMA20 -0.49%
SMA50 -2.33%
SMA200 7.98%
Trades
Volume 1,674,609
Change -0.92%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-04-24 Upgrade
Guggenheim
Neutral → Buy
Feb-13-24 Upgrade
Citigroup
Neutral → Buy
Jan-23-24 Initiated
Morgan Stanley
Equal-Weight
$44
Jan-16-24 Resumed
UBS
Buy
Jan-03-24 Upgrade
Jefferies
Hold → Buy
$48
Jul-14-23 Initiated
HSBC Securities
Reduce
Mar-17-23 Upgrade
Deutsche Bank
Hold → Buy
Feb-27-23 Resumed
Goldman
Buy
Jan-03-23 Downgrade
JP Morgan
Neutral → Underweight
Dec-05-22 Downgrade
BofA Securities
Neutral → Underperform
Nov-11-22 Downgrade
UBS
Neutral → Sell
Sep-15-22 Upgrade
Credit Suisse
Underperform → Neutral
Sep-08-22 Downgrade
Jefferies
Buy → Hold
$50.50 → $34
Aug-05-22 Resumed
Morgan Stanley
Equal-Weight
Jul-21-22 Resumed
Citigroup
Neutral
Feb-11-22 Downgrade
DZ Bank
Buy → Hold
Nov-05-21 Upgrade
Barclays
Underweight → Equal Weight
Jun-24-21 Upgrade
Deutsche Bank
Sell → Hold
Mar-23-21 Downgrade
SVB Leerink
Outperform → Mkt Perform
Feb-04-21 Downgrade
Deutsche Bank
Hold → Sell
Show Previous Ratings
Today 10:01AM
Apr-17-24 09:40AM
Apr-16-24 11:52AM
Apr-11-24 05:50PM
Apr-06-24 08:47PM
06:00PM
Loading…
Apr-05-24 06:00PM
05:52PM
(The Wall Street Journal)
Mar-28-24 09:00AM
Mar-27-24 09:17PM
Mar-26-24 06:15PM
09:53AM
05:10AM
Mar-24-24 03:54PM
03:23AM
Mar-22-24 10:54AM
06:00PM
Loading…
Mar-19-24 06:00PM
12:19PM
(The Wall Street Journal)
10:31AM
Mar-18-24 03:06PM
(The Wall Street Journal)
09:20AM
09:09AM
05:17AM
Mar-16-24 08:00AM
Mar-15-24 12:51PM
Mar-14-24 09:38AM
09:00AM
Mar-13-24 09:40AM
Mar-12-24 10:20AM
Mar-09-24 10:06AM
Mar-07-24 12:00PM
08:24AM
Loading…
08:24AM
Mar-06-24 08:03AM
(Pharmaceutical Business Review)
Mar-05-24 02:56AM
Mar-01-24 11:30AM
09:00AM
(The Wall Street Journal)
Feb-29-24 04:37PM
09:00AM
02:52AM
(The Wall Street Journal)
Feb-28-24 09:50AM
Feb-27-24 09:40AM
Feb-26-24 12:00PM
09:40AM
05:49AM
Feb-23-24 05:12AM
Feb-22-24 11:22AM
11:00AM
(The Wall Street Journal)
06:10AM
Feb-21-24 05:02AM
Feb-14-24 09:17AM
Feb-12-24 09:50AM
Feb-10-24 08:30AM
Feb-09-24 02:35PM
Feb-08-24 07:00AM
Feb-07-24 04:01PM
07:00AM
Feb-06-24 07:00AM
06:15AM
Feb-05-24 09:45PM
08:45PM
06:02AM
Feb-02-24 04:30PM
Feb-01-24 05:14PM
(The Wall Street Journal)
11:46AM
07:46AM
Jan-31-24 05:05PM
(The Wall Street Journal)
04:59PM
(The Wall Street Journal)
02:50PM
12:50PM
(The Wall Street Journal)
11:00AM
(The Wall Street Journal)
10:50AM
07:31AM
07:05AM
02:54AM
(The Wall Street Journal)
02:27AM
(The Wall Street Journal)
Jan-29-24 02:03PM
01:39AM
Jan-25-24 01:06PM
09:40AM
Jan-24-24 10:08AM
10:00AM
08:00AM
05:36AM
Jan-23-24 08:00AM
Jan-21-24 08:27AM
Jan-18-24 02:41PM
(The Wall Street Journal)
Jan-09-24 01:49PM
01:14PM
(The Wall Street Journal)
12:32PM
(The Wall Street Journal)
05:52AM
05:11AM
03:07AM
(The Wall Street Journal)
02:49AM
02:35AM
(The Wall Street Journal)
Jan-08-24 08:18PM
06:58AM
Jan-05-24 12:10PM
06:12AM
Jan-03-24 04:24AM
Dec-29-23 11:57AM
(The Wall Street Journal)
Dec-24-23 05:34PM
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GSK plc 10% Owner Dec 07 '23 Buy 5.00 3,300,000 16,500,000 13,983,761 Jan 30 04:39 PM
Category Equity - Leveraged / Inverse
Asset Type Equities (Stocks)
Tags U.S.
Return% 1Y -15.35%
Shs Outstand
Perf Week -3.27%
Sponsor ProShares
ETF Type
Tags equity
Return% 3Y -6.28%
Total Holdings 11
Perf Month 1.09%
Fund Family
Bond Type
Tags financial
Return% 5Y -12.61%
AUM 12.31M
Perf Quarter -6.34%
Index S&P Financial Select Sector Index
Average Maturity
Tags SP500
Return% 10Y
NAV%
Perf Half Y -22.27%
Index Weighting
Commodity Type
Tags inverse
Return% SI
NAV/sh
Perf Year -19.30%
Active/Passive
Quant Type
Tags -
Flows% 1M -7.75%
52W Range 10.16 - 13.78
Perf YTD -7.66%
Dividend TTM 0.55 (5.26% )
ESG Type
Tags -
Flows% 3M -3.05%
52W High -23.88%
Beta -0.99
Dividend Ex-Date Mar 20, 2024
Dividend Type
Sector/Theme
Flows% YTD -20.69%
52W Low 3.25%
ATR (14) 0.12
Expense 0.95%
Structure Type
Region
Flows% 1Y
RSI (14) 45.56
Volatility 0.92% 1.00%
Option/Short Yes / Yes
Growth/Value
Dev/Emerg
Flows% 3Y
Rel Volume 0.21
Prev Close 10.48
Inverse/Leveraged
Market Cap
Currency
Flows% 5Y
Avg Volume 50.55K
Price 10.49
SMA20 -0.05%
SMA50 -1.13%
SMA200 -11.61%
Trades
Volume 10,825
Change 0.14%
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite